We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

WHF:NASDAQWhiteHorse Finance, Inc. Analysis

Data as of 2026-09-02 - not real-time

$7.02

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

The moving-average structure behind WhiteHorse Finance, Inc. is neutral at $7.02, with no clear ordering between short and long averages. Across the trailing 30 sessions it gained 9.9%. Relative strength is 54.7 — neutral — and the MACD signal is bearish. Watch $6.53 as support and $7.30 as the nearer resistance level.
The shares look undervalued, trading on 9.1 times earnings below a sector average of 16.7. Analyst price targets sit 11.6% above the current price. Revenue is contracting at 23.7% on a 26.9% profit margin. The 14.11% dividend yield looks stretched against payout coverage.
On a 1-10 scale the risk profile lands at 7 — elevated. With 30-day volatility of 28.3%, a beta of 0.37 and a maximum drawdown of 29.9%, position sizing matters more than entry timing here. Thin trading volumes mean execution costs can be material on larger orders. The wider market backdrop reads extreme greed at 92 on the fear-greed composite.
All three time horizons resolve to buy, carrying 6/10 conviction.

Top Market Events

MIAMI AP — MIAMI AP — WhiteHorse Finance Inc.WhiteHorse Finance, Inc. To Report Second Quarter 2026 Financial Results PR Newswire NEW YORK, July 28, 2026 NEW YORK,...Seeking Alpha21dWhiteHorse Finance WHF Q2 2026 Earnings Call TranscriptGood afternoon, everyone.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 4/10

Key Factors

  • Trading above the 200-day average of 6.98
  • MACD momentum is negative
  • 30-day price change of +9.9%

Medium Term

1–3 years
Positive
Model confidence: 5/10

Key Factors

  • P/E of 9.1 versus sector average of 16.7
  • Dividend yield of 14.11% looks stretched against payout coverage
  • Trading above the 200-day average of 6.98

Long Term

> 3 years
Positive
Model confidence: 6/10

Key Factors

  • P/E of 9.1 versus sector average of 16.7
  • Dividend yield of 14.11% looks stretched against payout coverage
  • Analyst targets imply +11.6% versus the current price

Key Metrics & Analysis

Financial Health

Revenue Growth-23.70%
Profit Margin26.88%
P/E Ratio9.1
ROE6.65%
ROA4.33%
Debt/Equity128.34
P/B Ratio0.6
Op. Cash Flow$77.8M
Free Cash Flow$14.6M
Industry P/E16.7

Technical Analysis

TrendNeutral
RSI54.7
Support$6.53
Resistance$7.30
MA 20$7.00
MA 50$6.71
MA 200$6.98
MACDBearish
VolumeIncreasing
Fear & Greed Index92.21

Valuation

Target Price$7.83
Upside/Downside11.59%
GradeUndervalued
TypeValue
Dividend Yield14.11%

Risk Assessment

Beta0.37
Volatility28.33%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.